| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/02/1996 | CA2203280A1 Modified factor vii |
| 05/02/1996 | CA2203265A1 Production and use of human and plant methyltransferases |
| 05/02/1996 | CA2203255A1 Treatment of hla-dr-associated immunodeficiency with .gamma.-interferon |
| 05/02/1996 | CA2203165A1 Synthetic ige membrane anchor peptide immunogens for the treatment of allergy |
| 05/02/1996 | CA2203123A1 Hydroxyethyl aminimides |
| 05/02/1996 | CA2203105A1 Hippocampus-associated proteins, dna sequences coding therefor and uses thereof |
| 05/02/1996 | CA2203018A1 Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 05/02/1996 | CA2202912A1 Novel tnf receptor death domain ligand proteins and inhibitors of ligand binding |
| 05/02/1996 | CA2202891A1 Composition use of nucleoside analogues and gene transfection for tissue imaging and thereapy |
| 05/02/1996 | CA2202299A1 Compositions for the delivery of antigens |
| 05/02/1996 | CA2200869A1 Gene therapy involving concurrent and repeated administration of adenoviruses and immunosuppressive agents |
| 05/01/1996 | EP0709460A1 Coccidiosis poultry vaccine |
| 05/01/1996 | EP0709459A2 Modified biological material |
| 05/01/1996 | EP0709397A1 p53as Protein and antibody therefor |
| 05/01/1996 | EP0709097A1 Anti-Fas antibody for rheumatic disease |
| 05/01/1996 | EP0709096A2 Pharmaceutical conditionning unit containing plasminogen activators for a multiple bolus delivery |
| 05/01/1996 | EP0709081A1 Composition containing a precursor of dihydroacetone |
| 05/01/1996 | EP0708877A1 Method for repairing a combustion chamber assembly |
| 05/01/1996 | EP0708831A1 Density enhanced protein tyrosine phosphatases |
| 05/01/1996 | EP0708830A1 $i(BACILLUS THURINGIENSIS) ISOLATES AND TOXINS |
| 05/01/1996 | EP0708825A1 A fungal protein disulfide isomerase |
| 05/01/1996 | EP0708671A1 Drug delivery |
| 05/01/1996 | EP0708661A1 Transferrin receptor specific ligand-neuropharmaceutical agent fusion proteins |
| 05/01/1996 | EP0708660A1 Prodrugs of protein tyrosine kinase inhibitors |
| 05/01/1996 | EP0708657A1 Compositions for nasal administration of desmopressin |
| 05/01/1996 | EP0708655A1 Methods of using insulin-like growth factor binding proteins |
| 05/01/1996 | EP0708654A1 THF-$g(g)2 ANALOGS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM |
| 05/01/1996 | EP0708653A1 Assay and reagents for identifying anti-proliferative agents |
| 05/01/1996 | EP0708592A1 Mts gene, mutations therein, and methods for diagnosing cancer using mts gene sequence |
| 05/01/1996 | EP0491031B1 Cdr grafted anti-cea antibodies and their production |
| 05/01/1996 | EP0467954B1 Preparation of liposome and lipid complex compositions |
| 05/01/1996 | EP0441917B1 Pokeweed antiviral protein - monoclonal antibody conjugates |
| 05/01/1996 | CN1121725A Immunoparticles bearing monoclonal anti-CD4 antibodies and utilisation thereof |
| 05/01/1996 | CN1121723A 因子vii的纯化 The purified factor vii |
| 05/01/1996 | CN1121709A Oxytocin antagonist |
| 05/01/1996 | CN1121694A Cyclosporin-containing powder composition |
| 05/01/1996 | CN1121693A Oesteoblast growth stimulating composition containing PDGF and vitamin D |
| 05/01/1996 | CN1121429A Endoparasiticidal compositions |
| 05/01/1996 | CN1031714C Process for preparing urinary follicle stimulating hormone |
| 04/30/1996 | US5512675 Methods for preparing porphyrin-like compounds |
| 04/30/1996 | US5512661 Provides for nucleic acids encoding chimeric neurotrophic factors; for targeting active compounds to cells responsive to neurotropic factor |
| 04/30/1996 | US5512660 Purified ICAM-2 and fragment thereof |
| 04/30/1996 | US5512658 Pseudomonas exotoxins (PE) and conjugates thereof having lower animal toxicity with high cytocidal activity through substitution of positively charged amino acids |
| 04/30/1996 | US5512656 Immune system modulators |
| 04/30/1996 | US5512578 Administering bimodally-acting opioid agonist and excitatory opioid receptor antagonist |
| 04/30/1996 | US5512550 Method for inhibiting angiogenesis with modified platelet factor-4 and cleaved platelet factor-4 |
| 04/30/1996 | US5512549 Antidiabetic agents |
| 04/30/1996 | US5512548 CETP inhibitor polypeptide, antibodies against the synthetic polypeptide and prophylactic and therapeutic anti-atherosclerosis treatments |
| 04/30/1996 | US5512547 Pharmaceutical composition of botulinum neurotoxin and method of preparation |
| 04/30/1996 | US5512544 Pharmaceutical compositions comprising an anticytokine |
| 04/30/1996 | US5512473 Max-interacting proteins and related molecules and methods |
| 04/30/1996 | US5512460 Glia activating factor and its production |
| 04/30/1996 | US5512459 Transpeptization by contacting peptide and addition unit with thrombin to cleave leaving unit from core at enzyme cleavage site |
| 04/30/1996 | US5512457 Cytokine designated elk ligand |
| 04/30/1996 | US5512455 Atrial natriuretic peptide receptor protein |
| 04/30/1996 | US5512447 Methods for the diagnosis and treatment of diabetes |
| 04/30/1996 | US5512443 Second generation monoclonal antibodies having binding specificity to TAG-72 and human carcinomas and methods for employing the same |
| 04/30/1996 | US5512442 Using specific antibody binding |
| 04/30/1996 | US5512435 Receptor-binding antiproliferative peptides |
| 04/30/1996 | US5512434 Expression cloning of a human phosphatase |
| 04/30/1996 | US5512421 Generation, concentration and efficient transfer of VSV-G pseudotyped retroviral vectors |
| 04/30/1996 | US5512304 Method of preparing a thromboplastin extract |
| 04/30/1996 | US5512288 Administering culture product from medium containing bile |
| 04/30/1996 | US5512283 Methods for the selective suppression of an immune response to dust mite der Pi |
| 04/30/1996 | US5512282 Purified immunoglobulins comprising monospecific polyclonal antibodies to shiga-like toxin obtained by innoculating bovine animal with active shiga-like toxin, recovering immunoglobulins after animal has immune response to toxin |
| 04/30/1996 | US5512269 Method of treating retained pulmonary secretions |
| 04/30/1996 | CA1338302C Therapeutic octapeptide somatostatin analogs |
| 04/30/1996 | CA1338301C Therapeutic octapeptide somatostatin analogs |
| 04/29/1996 | CA2154543A1 Human 26s proteasome subunit components |
| 04/27/1996 | CA2134428A1 Neuropeptide y y2 agonist peptides |
| 04/25/1996 | WO1996012184A1 Diagnosis and monitoring process, and medicaments for the therapy of states of shock in human beings |
| 04/25/1996 | WO1996012033A1 Polycystic kidney disease gene |
| 04/25/1996 | WO1996012031A1 Process for preparing cyclosporin a |
| 04/25/1996 | WO1996012024A1 Cloning, expression and characterisation of a novel form of phosphatidylinositol-3-kinase |
| 04/25/1996 | WO1996012022A1 Intracellular isoform of the interleukin-1 receptor antagonist |
| 04/25/1996 | WO1996012021A2 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 04/25/1996 | WO1996012020A2 Hemoglobin receptors from neisseriae |
| 04/25/1996 | WO1996012019A2 Her4 human receptor tyrosine kinase or the epidermal growth factor receptor family |
| 04/25/1996 | WO1996012017A1 Gene participating in apoptosis |
| 04/25/1996 | WO1996012013A1 A NOVEL ENZYME WITH β-1,3-GLUCANASE ACTIVITY |
| 04/25/1996 | WO1996011955A1 Antigen-binding fusion proteins |
| 04/25/1996 | WO1996011954A1 Tc or re radiolabelled somatostatin analogs |
| 04/25/1996 | WO1996011953A1 N-terminally chemically modified protein compositions and methods |
| 04/25/1996 | WO1996011951A2 Keratinocyte growth factor analogs |
| 04/25/1996 | WO1996011950A1 Method of treating diabetes mellitus using kgf |
| 04/25/1996 | WO1996011949A2 Analogs of keratinocyte growth factor |
| 04/25/1996 | WO1996011948A1 Neurotrophic peptides of activity dependent neurotrophic factor |
| 04/25/1996 | WO1996011946A1 Human endothelin-bombesin receptor |
| 04/25/1996 | WO1996011943A1 New peptides with immunomodulatory effects |
| 04/25/1996 | WO1996011942A1 Therapeutic molecules |
| 04/25/1996 | WO1996011941A1 Dipeptide derivatives, process for producing them and medicaments containing these compounds |
| 04/25/1996 | WO1996011940A1 Acyl amino acetamide derivatives with agonist activity for cck-a receptors |
| 04/25/1996 | WO1996011938A1 Oligonucleotide and carcinostatic agent containing the same as active ingredient |
| 04/25/1996 | WO1996011712A2 Cell-specific gene delivery vehicles |
| 04/25/1996 | WO1996011706A1 Use of flea proteases and protease inhibitors to protect animals from flea infestation |
| 04/25/1996 | WO1996011705A1 Formulations comprising therapeutically-active proteins or polypeptides |
| 04/25/1996 | WO1996011704A1 A pharmaceutical formulation comprising a growth hormone and leucine |
| 04/25/1996 | WO1996011703A1 A pharmaceutical formulation comprising a growth hormone and isoleucine |
| 04/25/1996 | WO1996011702A1 A pharmaceutical formulation comprising a growth hormone and valine |
| 04/25/1996 | WO1996011701A1 Enteric coated compositions of 1,5-benzodiazepine derivatives having cck antagonistic or agonistic activity |